rifaximin
Showing 26 - 50 of 101
Weight Loss Trial in Dover (Rifaximin)
Not yet recruiting
- Weight Loss
- Rifaximin
-
Dover, DelawareBayhealth Medical Center- Dover Family Physicians and GI Consult
Dec 13, 2020
Hepatic Encephalopathy Trial in Richmond (Rifaximin, )
Completed
- Hepatic Encephalopathy
- Rifaximin
- placebo
-
Richmond, VirginiaHunter Holmes McGuire VA Medical Center
Dec 15, 2020
Rectal Cancer Trial in Basking Ridge, Commack, New York (Rifaximin, Placebo)
Active, not recruiting
- Rectal Cancer
- Rifaximin
- Placebo
-
Basking Ridge, New Jersey
- +2 more
Sep 21, 2021
Hepatic Encephalopathy, Liver Cirrhosis, End Stage Liver DIsease Trial (E.coli Nissle 1917, Lactulose, Rifaximin)
Completed
- Hepatic Encephalopathy
- +2 more
- E.coli Nissle 1917
- +2 more
- (no location specified)
Mar 5, 2021
Nonalcoholic Fatty Liver Disease, NAFLD, Nonalcoholic Steatohepatitis Trial in London (Rifaximin)
Terminated
- Nonalcoholic Fatty Liver Disease
- +2 more
- Rifaximin
-
London, United KingdomLiver Unit, St Mary's Hospital, Imperial College London
Oct 5, 2020
Hepatic Cirrhosis, Hepatic Encephalopathy (HE) Trial in Puerto Rico, United States (MNK6106, Rifaximin)
Completed
- Hepatic Cirrhosis
- Hepatic Encephalopathy (HE)
- MNK6106
- Rifaximin
-
Coronado, California
- +4 more
Jun 29, 2021
Small Bowel Disease, Rifaximin Trial in Beijing, Hong Kong (Rifaximin, Placebo oral tablet)
Recruiting
- Small Bowel Disease
- Rifaximin
- Rifaximin
- Placebo oral tablet
-
Beijing, Beijing, China
- +1 more
Jun 29, 2020
Decompensated Cirrhosis, Small Bowel Bacterial Overgrowth Syndrome Trial in Singapore (Rifaximin)
Recruiting
- Decompensated Cirrhosis
- Small Bowel Bacterial Overgrowth Syndrome
- Rifaximin
-
Singapore, SingaporeWong Yu Jun
Feb 25, 2021
IBS - Irritable Bowel Syndrome, Gut Microbiota Trial in Hangzhou (Rifaximin, Probiotic Formula, Placebo oral tablet)
Unknown status
- IBS - Irritable Bowel Syndrome
- Gut Microbiota
- Rifaximin
- +2 more
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, School of Medicine, Zhejiang Uni
Jul 26, 2020
Cirrhosis Trial in France (Rifaximin, )
Completed
- Cirrhosis
- Rifaximin
- placebo
-
Angers, France
- +12 more
Apr 21, 2020
Dyspepsia Trial in Lucknow (Rifaximin, Placebo)
Not yet recruiting
- Dyspepsia
- Rifaximin
- Placebo
-
Lucknow, UP, India
- +1 more
Mar 6, 2020
Diarrhea Trial in Guadalajara (Rifaximin, Placebo)
Completed
- Diarrhea
- Rifaximin
- Placebo
-
Guadalajara, Jalisco, MexicoUniversity of San Diego
Dec 3, 2019
Pharmacokinetic Trial (rifaximin)
Completed
- Pharmacokinetic
- rifaximin
- (no location specified)
Nov 26, 2019
Diarrhea Trial in South Miami, Houston, La Porte (Rifaximin)
Completed
- Diarrhea
- Rifaximin
-
South Miami, Florida
- +2 more
Nov 21, 2019
Hepatic Encephalopathy Trial in Miami (Rifaximin, Lactulose, Placebo)
Terminated
- Hepatic Encephalopathy
- Rifaximin
- +2 more
-
Miami, FloridaCenter For Liver Diseases - University of Miami
Aug 27, 2019
Travelers' Diarrhea, Functional Bowel Disorders, Reactive Arthritis Trial in Kenya, United States (Rifaximin, Placebo)
Unknown status
- Travelers' Diarrhea
- +2 more
- Rifaximin
- Placebo
-
San Diego, California
- +5 more
Nov 25, 2019
Refractory Hepatic Encephalopathy Trial in New Delhi (Lactulose, Rifaximin, Plasmapheresis)
Withdrawn
- Refractory Hepatic Encephalopathy
- Lactulose
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Nov 1, 2019
Transcranial Doppler Ultrasound and Minimal Hepatic
Completed
- Minimal Hepatic Encephalopathy
- Rifaximin
-
Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Aug 30, 2019
Hepatic Encephalopathy Trial in Tanta (Rifaximin, Nitazoxanide)
Recruiting
- Hepatic Encephalopathy
- Rifaximin
- Nitazoxanide
-
Tanta, EgyptSherief Abd-Elsalam
Nov 12, 2019